Full Press Release Details
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4).
IRON
Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)
Key Takeaway: Disc Medicine Reports Inducement Grant under Nasdaq Listing Rule 5635(C)(4)
Price reaction · baseline $59.95 (2025-01-16 close) · hit after-hours · 4 other IRON headline(s) in the window, move may be shared
day 0 close · peak
-2.8%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+45%
120-day peak, hindsight
Typical move
3.9%
average across 7 past catalysts
Cash runway
~48 mo
Minimal dilution risk
Lead asset
DISC-0974
Phase 2 · Inflammatory Bowel Disease (IBD)